Diyong Xu
CIK: 0001995088
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Q32 Bio Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 12, 2026QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
10.8K shares- - Jun 12, 2026QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
9.8K shares- - May 28, 2026QTTB
Q32 Bio Inc.
Purchase(P)Indirect625K shares at avg. $8.00$5.0M - May 28, 2026QTTB
Q32 Bio Inc.
Purchase(P)Indirect1.3M shares at avg. $8.00$10.0M - Oct 23, 2025QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
53.5K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Disposition(D)DirectStock Option (Right to Buy)
12.8K shares- - Feb 24, 2025QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
12.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 10,826 | - | - | Direct |
| Jun 12, 2026 | QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 9,810 | - | - | Direct |
| May 28, 2026 | QTTB Q32 Bio Inc. | Purchase(P) | 625,000 | $8.00 | $5,000,000 | Indirect |
| May 28, 2026 | QTTB Q32 Bio Inc. | Purchase(P) | 1,250,000 | $8.00 | $10,000,000 | Indirect |
| Oct 23, 2025 | QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 53,521 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Disposition(D) Stock Option (Right to Buy) | 12,767 | - | - | Direct |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 12,767 | - | - | Direct |
1-7 of 7 transactions
About Xu Diyong
Xu Diyong (SEC CIK 0001995088) files insider reports with the SEC as Director of Q32 Bio Inc. (QTTB).
Signal8 holds 5 ownership filings by Xu Diyong, all Form 4s, filed between Feb 26, 2025 and Jul 21, 2026. Those filings report 7 transactions, from Feb 24, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Xu Diyong's filings is in WALTHAM, MA.
Recent filings by Xu Diyong
- Jun 12, 2026: Grants or awards of QTTB derivative securities (2 lines, Form 4, code A).
- May 28, 2026: Open-market purchases of QTTB shares (2 lines, Form 4, code P).
- Oct 23, 2025: Grant or award of QTTB derivative securities (Form 4, code A).
- Feb 24, 2025: Disposition to issuer transaction of QTTB derivative securities (Form 4, code D).
- Feb 24, 2025: Grant or award of QTTB derivative securities (Form 4, code A).
Other insiders filing for Q32 Bio Inc. (QTTB)
- Morrison Jodie Pope, CEO
- Violette Shelia M., Chief Scientific Officer
- Kalowski Lee, CFO and President
- TZIANABOS ARTHUR, Director
- Lundberg Sven Ante, Director
- LAPORTE KATHLEEN, Director